New insights into Parkinson’s Disease

A slew of recent studies sheds light on the neurodegenerative disorder Parkinson disease.

Written byTia Ghose
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Histological sample of Substantia nigra in Parkinson's diseaseWIKIMEDIA COMMONS, WERGER CJ, HEYNY

Several recent studies provide new insight into Parkinson’s disease. Nine Parkinson’s patients showed improvements in walking and dexterity after receiving brain injections of a gene therapy to boost dopamine production, the Oxford Times reports. The treatment, ProSavin, was developed by Oxford Biomedica and is still in initial safety trails. Science News reported that H. pylori, the bacteria responsible for stomach ulcers, can trigger Parkinson’s symptoms in mice. Past studies had shown only a circumstantial link. Researchers at Louisiana State University Health Sciences Center in Shreveport aren’t sure how H. pylori triggered the disease, but they noted that the bacteria stole a cholesterol molecule from its host and modified it to resemble a tropical toxin known to cause Parkinsonism. And a new meta-analysis in the June ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies